A Review of the Scientific Contributions of Nepal on COVID-19.
Bibliometrics
COVID-19
Coronavirus
Pandemic
SARS-CoV-2
Journal
Current tropical medicine reports
ISSN: 2196-3045
Titre abrégé: Curr Trop Med Rep
Pays: Switzerland
ID NLM: 101625249
Informations de publication
Date de publication:
2021
2021
Historique:
accepted:
08
07
2021
pubmed:
9
11
2021
medline:
9
11
2021
entrez:
8
11
2021
Statut:
ppublish
Résumé
There has been a high influx of publications on the SARS-CoV-2 and COVID-19 worldwide in the recent few months as very little was known about them. Nepal too had a substantial number of publications on the same, and there was a need to track the most relevant and impactful to the scientific community through bibliometric analysis. A total of 72 publications were analyzed. Bagmati Pradesh (88%) and its district, Kathmandu (77%), was with the most publications. There were no publications from Gandaki and Karnali Province. Most of the publications were in the international medical journals (82%), 53% chose European journals to publish, and 15.27% were related to and published in psychology journals. The majority were original articles (39%) and mostly related to public health (20.83%). 59.7% of the papers had Nepalese as the first author. Most of them were affiliated with Tribhuvan University Teaching Hospital and Patan Academy of Health Sciences. Our analysis suggests a need to shift the type of studies from observational studies to studies oriented more towards the therapeutic and clinical trials of available medicines and patient care management. Similarly, the bibliometric analysis gives an overall picture of Nepali medical research's publication status around the globe.
Identifiants
pubmed: 34745841
doi: 10.1007/s40475-021-00247-0
pii: 247
pmc: PMC8558546
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
257-264Informations de copyright
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021.
Déclaration de conflit d'intérêts
Conflict of InterestThe authors declare no competing interests.
Références
J Nepal Health Res Counc. 2012 Sep;10(22):243-9
pubmed: 23281460
Clin Microbiol Infect. 2020 Aug;26(8):988-998
pubmed: 32454187
Global Health. 2021 Mar 25;17(1):31
pubmed: 33766073
J Med Chem. 2020 Dec 24;63(24):15073-15074
pubmed: 33264005
Hum Vaccin Immunother. 2021 Aug 3;17(8):2367-2372
pubmed: 33687303
J Biosaf Biosecur. 2021 Jun;3(1):4-9
pubmed: 33521590
BMC Med Res Methodol. 2021 Jan 4;21(1):1
pubmed: 33397292
J Vis Exp. 2019 Oct 24;(152):
pubmed: 31710021
J Travel Med. 2020 May 18;27(3):
pubmed: 32104884
BMC Med Res Methodol. 2020 Jun 22;20(1):161
pubmed: 32571302
Ther Adv Drug Saf. 2020 Jun 12;11:2042098620922480
pubmed: 32587678
Infect Dis (Auckl). 2020 Oct 13;13:1178633720962935
pubmed: 33110348
Arch Cardiol Mex. 2020 Nov 04;91(Suplemento COVID):001-011
pubmed: 33147597
BMC Infect Dis. 2020 Aug 1;20(1):561
pubmed: 32738881
Biomed Pharmacother. 2020 Sep;129:110451
pubmed: 32603887
Ann Transl Med. 2020 Jul;8(13):816
pubmed: 32793661
Innovation (Camb). 2020 Aug 28;1(2):100027
pubmed: 32914141
J Family Community Med. 2021 Jan-Apr;28(1):1-7
pubmed: 33679183
Int J Equity Health. 2018 Mar 22;17(1):37
pubmed: 29566721
Scientometrics. 2020;124(3):2687-2701
pubmed: 32836524
Asia Pac J Public Health. 2010 Oct;22(4):492-500
pubmed: 20462852
Croat Med J. 2007 Apr;48(2):261-7
pubmed: 17436392
PLoS One. 2020 Oct 6;15(10):e0240123
pubmed: 33022014
Cureus. 2020 Mar 21;12(3):e7357
pubmed: 32328369
PLoS Biol. 2021 Apr 2;19(4):e3000959
pubmed: 33798194
PeerJ. 2021 Mar 03;9:e10927
pubmed: 33717688
Ann Transl Med. 2020 Apr;8(8):528
pubmed: 32411751